Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Hypertension

Free Subscription 09.10.2023 1 Am J Cardiol 1 Am J Epidemiol 4 Am J Hypertens 2 Clin Cardiol 2 Hypertension 2 J Cardiovasc Pharmacol 2 J Hum Hypertens 21 J Hypertens 1 JAMA 1 Kidney Int 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. KRISHTOPAYTIS E, Ampnti SA, Obeidat M, Ramahi N, et al
   Can Inhaled Nitric Oxide Response Predict Tolerance to Therapies and Survival in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension?
   Am J Cardiol. 2023;207:363-369.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. FRANCIS B, Pearl M, Colen C, Shoben A, et al
   Racial and Economic Segregation Over the Lifecourse and Incident Hypertensive Disorders of Pregnancy among Black Women in California.
   Am J Epidemiol. 2023 Sep 28:kwad192. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Hypertens

3. SARNHOLM J, Kronish IM
   Psychological distress and hypertension diagnostic testing: Is there anything to worry about?
   Am J Hypertens. 2023 Oct 5:hpad096. doi: 10.1093.
   PubMed        
   
   
4. ZANUZZI MG, Lopez SM, Cattaneo MJ, Perez-Maure MA, et al
   Isolated Nocturnal Hypertension in People Living with Human Immunodeficiency Virus (PWH): A Cross-Sectional Study.
   Am J Hypertens. 2023 Sep 30:hpad087. doi: 10.1093.
   PubMed         Abstract available
   
   
5. SRIPERUMBUDURI S, Welling P, Ruzicka M, Hundemer GL, et al
   Potassium and Hypertension: A State-of-the-Art Review.
   Am J Hypertens. 2023 Sep 29:hpad094. doi: 10.1093.
   PubMed         Abstract available
   
   
6. LEE JS, Bhatt A, Jackson SL, Pollack LM, et al
   Rural and Urban Differences in Hypertension Management Through Telehealth Before and During the COVID-19 Pandemic Among Commercially Insured Patients.
   Am J Hypertens. 2023 Sep 29:hpad093. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

7. NIU J, Xu D, Huang Y, You J, et al
   Sex-related association of modifiable risk factors with hypertension: A national cross-sectional study of NHANES 2007-2018.
   Clin Cardiol. 2023 Oct 5. doi: 10.1002/clc.24165.
   PubMed         Abstract available
   
   
8. DI GIACOMO D, Ranieri J, Guerra F, Cilli E, et al
   Cardiovascular risk and biopsychosocial interplay: Association among hypertension, anxiety, and emotional dysregulation-observational study in primary care setting for efficient self-care.
   Clin Cardiol. 2023 Sep 28. doi: 10.1002/clc.24152.
   PubMed         Abstract available
   
   

   
   Hypertension

9. ZHANG J, Yin Z, Xu Y, Wei C, et al
   Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice.
   Hypertension. 2023 Oct 6. doi: 10.1161/HYPERTENSIONAHA.123.21348.
   PubMed         Abstract available
   
   
10. MANCIA G, Kjeldsen SE
    Randomized Clinical Outcome Trials in Hypertension.
    Hypertension. 2023 Oct 5. doi: 10.1161/HYPERTENSIONAHA.123.21725.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

11. LIU R, Staruschenko A
    Matrix Metalloproteinase 2 is crucial for hypertension- and hyperglycemia-induced kidney injury independent of blood pressure.
    J Cardiovasc Pharmacol. 2023 Sep 28. doi: 10.1097/FJC.0000000000001488.
    PubMed        
    
    
12. KAPLAN A, Lakkis B, El-Samadi L, Karaayvaz EB, et al
    Cooling Down Inflammation in the Cardiovascular System via the Nicotinic Acetylcholine Receptor.
    J Cardiovasc Pharmacol. 2023 Aug 4. doi: 10.1097/FJC.0000000000001455.
    PubMed         Abstract available
    
    

    
    J Hum Hypertens

13. GOSSE P, Boulestreau R, Doublet J, Gaudissard J, et al
    Arterial stiffness (from monitoring of Qkd interval) predict the occurrence of cardiovascular events and total mortality.
    J Hum Hypertens. 2023;37:907-912.
    PubMed         Abstract available
    
    
14. KOURTIDOU C, Georgianos PI, Vaios V, Liakopoulos V, et al
    Prescribing the optimal dialysate sodium concentration for managing hypertension and volume overload in hemodialysis: one size does not fit to all patients.
    J Hum Hypertens. 2023 Oct 4. doi: 10.1038/s41371-023-00870.
    PubMed        
    
    

    
    J Hypertens

15. WIERSINGA JHI, Rhodius-Meester HFM, Wolters FJ, Trappenburg MC, et al
    Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population.
    J Hypertens. 2023;41:1738-1744.
    PubMed         Abstract available
    
    
16. LEE SH, Lee CJ, Kang Y, Park JM, et al
    A randomized trial of genotype-guided perindopril use.
    J Hypertens. 2023;41:1768-1774.
    PubMed         Abstract available
    
    
17. SCHMIDT-LAUBER C, Alba Schmidt E, Hanzelmann S, Petersen EL, et al
    Increased blood pressure after nonsevere COVID-19.
    J Hypertens. 2023;41:1721-1729.
    PubMed         Abstract available
    
    
18. SONG J, Tan M, Wang C, Brown MK, et al
    Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
    J Hypertens. 2023;41:1713-1720.
    PubMed         Abstract available
    
    
19. BROSOLO G, Da Porto A, Bulfone L, Vacca A, et al
    Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003590.
    PubMed         Abstract available
    
    
20. SULICKA-GRODZICKA J, Guzik TJ
    The ATP connection: a new therapeutic promise of P2X7 targeting in hypertension and vascular injury.
    J Hypertens. 2023;41:1696-1698.
    PubMed        
    
    
21. SHOKOPLES BG, Berillo O, Comeau K, Chen HY, et al
    P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation.
    J Hypertens. 2023;41:1701-1712.
    PubMed         Abstract available
    
    
22. SHI M, Liu Y, Wang S, Wang R, et al
    Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke.
    J Hypertens. 2023;41:1730-1737.
    PubMed         Abstract available
    
    
23. CARDOSO AM, Aneli NM, Lammers M, Manica A, et al
    Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling.
    J Hypertens. 2023;41:1745-1752.
    PubMed         Abstract available
    
    
24. FATIMA HE, Lo DF
    Examining the impact of E-health management on hypertension.
    J Hypertens. 2023;41:1863.
    PubMed        
    
    
25. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    Reply to 'Examining the impact of E-health management on hypertension'.
    J Hypertens. 2023;41:1864.
    PubMed        
    
    
26. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.
    J Hypertens. 2023;41:1864-1865.
    PubMed        
    
    
27. CUSPIDI C, Gherbesi E, Tadic M
    Phenotyping masked hypertension: do not forget the night.
    J Hypertens. 2023;41:1865-1866.
    PubMed        
    
    
28. TABARA Y
    Reply to 'Phenotyping sleep hypertension; never forgetting the night'.
    J Hypertens. 2023;41:1867.
    PubMed        
    
    
29. 
    PS-P12-8: The prevalence of hypertension in factory employees, detected during the periodic examination at the factory: Erratum.
    J Hypertens. 2023;41:1868.
    PubMed        
    
    
30. 
    Prevalence of non-steroidal anti-inflammatory drugs (NSAIDS) use in patients with hypertensive crisis: Erratum.
    J Hypertens. 2023;41:1871.
    PubMed        
    
    
31. 
    Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    J Hypertens. 2023;41:1872.
    PubMed        
    
    
32. RIJAL A, Adhikari TB, Dhakal S, Maagaard M, et al
    Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003589.
    PubMed         Abstract available
    
    
33. BASTA K, Ledwaba-Chapman L, Dodhia H, Ashworth M, et al
    Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021.
    J Hypertens. 2023 Oct 2. doi: 10.1097/HJH.0000000000003584.
    PubMed         Abstract available
    
    
34. PEETERS LEJ, Kappers MHW, Hesselink DA, van der Net JB, et al
    Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003585.
    PubMed         Abstract available
    
    
35. DE LA SIERRA A, Ruilope LM, Martinez-Camblor P, Vinyoles E, et al
    Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.
    J Hypertens. 2023 Sep 27. doi: 10.1097/HJH.0000000000003581.
    PubMed         Abstract available
    
    

    
    JAMA

36. HARRIS E
    Majority of People Live With Uncontrolled Hypertension Worldwide.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19204.
    PubMed        
    
    

    
    Kidney Int

37. EMMONS BR, Batal I, Radhakrishnan J, Husain SA, et al
    Age-related changes in nephrosclerosis in a multiethnic living kidney donor cohort.
    Kidney Int. 2023;104:394-397.
    PubMed        
    
    

    
    Neurology

38. KELLY DM, Georgakis MK, Franceschini N, Blacker D, et al
    Interplay Between Chronic Kidney Disease, Hypertension, and Stroke: Insights From a Multivariable Mendelian Randomization Analysis.
    Neurology. 2023 Sep 29:10.1212/WNL.0000000000207852.
    PubMed         Abstract available
    
    

    
    PLoS One

39. COSTA S, Guerreiro J, Teixeira I, Helling DK, et al
    Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmacia(R)).
    PLoS One. 2023;18:e0292308.
    PubMed         Abstract available
    
    
40. LEE H, Kim H, Oh S, Park JK, et al
    Delayed blood pressure recovery after exercise stress test is associated with autonomic dysfunction and pulse pressure in a middle-aged healthy group.
    PLoS One. 2023;18:e0285961.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.